Print Page Print Page  |  RSS Feeds RSS Feeds  |  E-mail Alerts E-mail Alerts  |  IR Contacts IR Contacts  |  Financial Tear Sheet Financial Tear Sheet

CORPORATE INFORMATION

Where is Delcath's headquarters?
 Delcath is headquartered in New York, NY. Our mailing address is:
1633 Broadway, 22nd Floor, Suite C
New York, NY 10019
Telephone: (212) 489-2100
Fax: (212) 489-2102

When was Delcath founded?
 Delcath was founded in 1988.

Where is Delcath incorporated?
 Delcath is incorporated in Delaware.

What is Delcath’s fiscal year?
 Delcath’s fiscal year ends on December 31.


Which stock exchange lists Delcath and what is the ticker symbol?
 We are listed on the OTC QB stock exchange under the ticker symbol DCTH

FINANCIAL / SHAREHOLDER INFORMATION

On which exchange is Delcath listed and what is the ticker symbol?
 Delcath is quoted on the NASDAQ Capital Market under the ticker symbol DCTH.

In what year did Delcath go public?
 Delcath began trading on the NASDAQ under the ticker symbol DCTH on October 22, 2001.

Who do I contact regarding lost stock certificates, address changes, and changes of ownership or name in which shares are held?
 Please contact Delcath's transfer agent, American Stock Transfer and Trust Company, LLC
6201 15th Ave.
Brooklyn, NY 11219
1-800-937-5449
www.amstock.com

What is the stock’s CUSIP number?
 The CUSIP number is 24661P.

Can I purchase stock directly from Delcath?
 Delcath does not have a direct purchase program. You must purchase stock through your broker.

Has Delcath had any stock splits?
 

On July 19, 2016, at our 2016 annual meeting of stockholders, our stockholders approved a reverse stock split at one of six ratios of 1-for-10, 1-for-12, 1-for-14, 1-for-16, 1-for-18 or 1-for-20, in the discretion of our board of directors. On the same date, the Board of Directors determined to effect a reverse stock split of the Company’s common stock at a 1-for-16 ratio (the “2016 Reverse Stock Split”). The 2016 Reverse Stock Split became effective as of 9:00 a.m. EDT on July 21, 2016. At the same meeting, our stockholders approved an amendment to our Certificate of Incorporation to increase the number of our authorized shares of Common Stock to 500,000,000.

On February 24, 2014, shareholders of the Company approved, through a shareholder vote, an amendment to the Company’s Amended and Restated Certificate of Incorporation authorizing the Board of Directors to effect a reverse stock split of Delcath’s common stock at a ratio within a range of one-for-eight (1:8) to one-for-sixteen (1:16). The reverse stock split became effective on April 8, 2014 at which time Delcath’s common stock began trading on the NASDAQ Stock Exchange on a one-for-sixteen (1:16) split-adjusted basis.


Has Delcath repurchased any stock?
 Delcath has not repurchased any stock.

What is Delcath's policy on dividends and dividend reinvestment plans?
 Delcath has never paid any cash dividends on our common stock and we do not anticipate paying cash dividends in the foreseeable future and will subsequently not propose a dividend reinvestment plan. Delcath believes in reinvesting in research & development, the key driver of future growth for the company.

Who are Delcath's independent auditors?
 Our independent auditors are Grant Thornton, LLP.


CORPORATE GOVERNANCE INFORMATION

Where can I get information on Delcath’s Corporate Governance practices?
 Please visit the following section of our website to read our corporate governance guidelines.

How can I contact Delcath’s Board of Directors?
 Any stockholder wishing to communicate with the board or with any specified director should address their communication to the board of directors or to the particular director(s) in care of: Corporate Secretary, Delcath Systems, Inc., 1633 Broadway, 22nd Floor, Suite C, New York, NY 10019. Please use this mail address to contact the board of directors for legitimate business inquiries only. Solicitations of any kind will be discarded.

How many members of the Delcath board of directors are independent under SEC standards?
 The board has determined that a majority of our incumbent directors –William D. Rueckert, Marco Taglietti,– are “independent” directors within the definition of NASDAQ rules.

Is the chair of Delcath’s audit committee independent?
 Yes. The audit committee is led by William D. Rueckert.